99 related articles for article (PubMed ID: 10886156)
21. A 10-year follow-up of a child with mild case of xeroderma pigmentosum complementation group D diagnosed by whole-genome sequencing.
Ono R; Masaki T; Mayca Pozo F; Nakazawa Y; Swagemakers SM; Nakano E; Sakai W; Takeuchi S; Kanda F; Ogi T; van der Spek PJ; Sugasawa K; Nishigori C
Photodermatol Photoimmunol Photomed; 2016 Jul; 32(4):174-80. PubMed ID: 26993158
[TBL] [Abstract][Full Text] [Related]
22. [Siblings with xeroderma pigmentosum group A showing mild cutaneous and various neurological manifestations].
Kuru S; Yasuma M; Sakai M; Konagaya M; Moriwaki S
Rinsho Shinkeigaku; 2006 Feb; 46(2):134-9. PubMed ID: 16619838
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a splicing mutation in group A xeroderma pigmentosum.
Satokata I; Tanaka K; Miura N; Miyamoto I; Satoh Y; Kondo S; Okada Y
Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9908-12. PubMed ID: 1702221
[TBL] [Abstract][Full Text] [Related]
24. [Photosensitive disorders--focusing on photosensitive genetic diseases].
Nishigori C
Nihon Rinsho; 2010 Jun; 68(6):1187-95. PubMed ID: 20535974
[TBL] [Abstract][Full Text] [Related]
25. Quantitative analysis of brain atrophy in patients with xeroderma pigmentosum group A carrying the founder mutation in Japan.
Ueda T; Kanda F; Nishiyama M; Nishigori C; Toda T
J Neurol Sci; 2017 Oct; 381():103-106. PubMed ID: 28991657
[TBL] [Abstract][Full Text] [Related]
26. A novel XPA gene mutation and its functional analysis in a Japanese patient with xeroderma pigmentosum group A.
Tanioka M; Budiyant A; Ueda T; Nagano T; Ichihashi M; Miyachi Y; Nishigori C
J Invest Dermatol; 2005 Aug; 125(2):244-6. PubMed ID: 16098033
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity to UV radiation of fibroblasts from a Japanese group A xeroderma pigmentosum patient with mild neurological abnormalities.
Sato K; Watatani M; Ikenaga M; Kozuka T; Kitano Y; Yoshikawa K; Mimaki T; Abe J; Sugita T
Br J Dermatol; 1987 Jan; 116(1):101-8. PubMed ID: 3814505
[TBL] [Abstract][Full Text] [Related]
28. A summary of mutations in the UV-sensitive disorders: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy.
Cleaver JE; Thompson LH; Richardson AS; States JC
Hum Mutat; 1999; 14(1):9-22. PubMed ID: 10447254
[TBL] [Abstract][Full Text] [Related]
29. Elevated Urinary Levels of 8-Hydroxy-2'-deoxyguanosine in a Japanese Child of Xeroderma Pigmentosum/Cockayne Syndrome Complex with Infantile Onset of Nephrotic Syndrome.
Kondo D; Noguchi A; Tamura H; Tsuchida S; Takahashi I; Kubota H; Yano T; Oyama C; Sawaishi Y; Moriwaki S; Takahashi T
Tohoku J Exp Med; 2016 Jul; 239(3):231-5. PubMed ID: 27396511
[TBL] [Abstract][Full Text] [Related]
30. Homozygous R788W point mutation in the XPF gene of a patient with xeroderma pigmentosum and late-onset neurologic disease.
Sijbers AM; van Voorst Vader PC; Snoek JW; Raams A; Jaspers NG; Kleijer WJ
J Invest Dermatol; 1998 May; 110(5):832-6. PubMed ID: 9579555
[TBL] [Abstract][Full Text] [Related]
31. Mutations in the XPD gene in xeroderma pigmentosum group D cell strains: confirmation of genotype-phenotype correlation.
Kobayashi T; Uchiyama M; Fukuro S; Tanaka K
Am J Med Genet; 2002 Jul; 110(3):248-52. PubMed ID: 12116233
[TBL] [Abstract][Full Text] [Related]
32. Identification of splicing mutations of the last nucleotides of exons, a nonsense mutation, and a missense mutation of the XPAC gene as causes of group A xeroderma pigmentosum.
Satokata I; Tanaka K; Yuba S; Okada Y
Mutat Res; 1992 Mar; 273(2):203-12. PubMed ID: 1372103
[TBL] [Abstract][Full Text] [Related]
33. Clinical profile and mutation analysis of xeroderma pigmentosum in Indian patients.
Tamhankar PM; Iyer SV; Ravindran S; Gupta N; Kabra M; Nayak C; Kura M; Sanghavi S; Joshi R; Chennuri VS; Khopkar U
Indian J Dermatol Venereol Leprol; 2015; 81(1):16-22. PubMed ID: 25566891
[TBL] [Abstract][Full Text] [Related]
34. Human disorders showing increased sensitivity to the induction of genetic damage.
Arlett CF; Lehmann AR
Annu Rev Genet; 1978; 12():95-115. PubMed ID: 371535
[No Abstract] [Full Text] [Related]
35. Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels.
Chavanne F; Broughton BC; Pietra D; Nardo T; Browitt A; Lehmann AR; Stefanini M
Cancer Res; 2000 Apr; 60(7):1974-82. PubMed ID: 10766188
[TBL] [Abstract][Full Text] [Related]
36. DNA-based prenatal diagnosis in a Chinese family with xeroderma pigmentosum group A.
Yang Y; Ding B; Wang K; Bu D; Tu P; Zhu X
Br J Dermatol; 2004 Jun; 150(6):1190-3. PubMed ID: 15214909
[TBL] [Abstract][Full Text] [Related]
37. Xeroderma pigmentosum clinical practice guidelines.
Moriwaki S; Kanda F; Hayashi M; Yamashita D; Sakai Y; Nishigori C;
J Dermatol; 2017 Oct; 44(10):1087-1096. PubMed ID: 28771907
[TBL] [Abstract][Full Text] [Related]
38. Molecular studies of Japanese patients with group A xeroderma pigmentosum using polymerase chain reaction and restriction fragment length polymorphism and nonradioactive single strand conformation polymorphism analyses.
Sumitani S; Ishikawa Y; Ishikawa Y; Minami R
J Child Neurol; 1999 Mar; 14(3):168-72. PubMed ID: 10190268
[TBL] [Abstract][Full Text] [Related]
39. [Novel mutations of XPC gene detected in a family affected with xeroderma pigmentosum group C].
Wang L; Huang S; Li J; Zou Y; Xu P; Gao M; Kang R; Xie H; Wei X; Niu Y; Liu X; Gao Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Aug; 35(4):540-543. PubMed ID: 30098252
[TBL] [Abstract][Full Text] [Related]
40. Functional and molecular genetic analyses of nine newly identified XPD-deficient patients reveal a novel mutation resulting in TTD as well as in XP/CS complex phenotypes.
Schäfer A; Gratchev A; Seebode C; Hofmann L; Schubert S; Laspe P; Apel A; Ohlenbusch A; Tzvetkov M; Weishaupt C; Oji V; Schön MP; Emmert S
Exp Dermatol; 2013 Jul; 22(7):486-9. PubMed ID: 23800062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]